Susquehanna International Group, LLP Igm Biosciences, Inc. Call Options Transaction History

Susquehanna International Group, LLP

  • $527 Billion
  • Q2 2024

Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$3.94 - $8.79 $42,158 - $94,052
10,700 New
10,700 $88,000
Q1 2023

May 16, 2023
BUY
$13.74 - $25.76 $303,654 - $569,296
22,100 New
22,100 $303,000
Q3 2022

Nov 14, 2022
SELL
$15.42 - $27.01 $678,480 - $1.19 Million
-44,000 Reduced 75.99%
13,900 $316,000
Q2 2022

Aug 15, 2022
SELL
$13.27 - $25.5 $577,245 - $1.11 Million
-43,500 Reduced 42.9%
57,900 $1.04 Million
Q1 2022

May 16, 2022
BUY
$13.42 - $29.73 $1.05 Million - $2.32 Million
77,900 Added 331.49%
101,400 $2.71 Million
Q4 2021

Feb 14, 2022
BUY
$27.59 - $66.39 $212,443 - $511,203
7,700 Added 48.73%
23,500 $689,000
Q3 2021

Nov 15, 2021
BUY
$65.76 - $90.65 $486,624 - $670,810
7,400 Added 88.1%
15,800 $1.04 Million
Q2 2021

Aug 11, 2021
SELL
$57.98 - $96.6 $626,184 - $1.04 Million
-10,800 Reduced 56.25%
8,400 $699,000
Q1 2021

May 17, 2021
SELL
$71.56 - $121.23 $400,736 - $678,888
-5,600 Reduced 22.58%
19,200 $1.47 Million
Q4 2020

Feb 16, 2021
SELL
$47.41 - $115.03 $6.41 Million - $15.6 Million
-135,300 Reduced 84.51%
24,800 $2.19 Million
Q3 2020

Nov 16, 2020
BUY
$43.0 - $84.01 $6.88 Million - $13.5 Million
160,100 New
160,100 $11.8 Million

Others Institutions Holding IGMS

# of Institutions
89
Shares Held
21.4M
Call Options Held
39.5K
Put Options Held
16.5K
View Full List

About IGM Biosciences, Inc.

IGMS Quotes by TradingView
  • Ticker IGMS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,969,000
  • Market Cap $500M
  • Description
  • IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...
More about IGMS
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email